Medartis Holding AG
· ISIN: CH0386200239
· EQS - adhoc news
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News Medartis Holding AG
In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
This might be interesting for you as well
18 March 2025 06:59AM
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
Medartis Holding AG / Key word(s): Annual Results/Forecast
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19% 18-March-2025 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
20 August 2024 07:05AM
Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
Medartis Holding AG / Key word(s): Half Year Results
Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17% 20-Aug-2024 / 07:05 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
09 July 2024 06:59AM
Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis
Medartis Holding AG / Key word(s): Personnel
Basel, 9th July 2024
Matthias Schupp appointed as CEO of Medartis 09-Jul-2024 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
11 June 2024 06:59AM
Basel, 11th June 2024 Medartis announces resignation of CEO Christoph Brönnimann
Medartis Holding AG / Key word(s): Personnel
Basel, 11th June 2024
Medartis announces resignation of CEO Christoph Brönnimann 11-Jun-2024 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
11 June 2024 06:59AM
Basel, 11th June 2024 Medartis announces resignation of CEO Christoph Brönnimann
Medartis Holding AG / Key word(s): Personnel
Basel, 11th June 2024
Medartis announces resignation of CEO Christoph Brönnimann 11-Jun-2024 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
04 April 2024 07:25AM
Medartis successfully places CHF 115.8 million convertible bonds due 2031
Medartis Holding AG / Key word(s): Bond/Financing
Medartis successfully places CHF 115.8 million convertible bonds due 2031 04-Apr-2024 / 07:25 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
03 April 2024 05:43PM
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031
Medartis Holding AG / Key word(s): Financing/Issue of Debt
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031 03-Apr-2024 / 17:43 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
03 April 2024 05:43PM
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031
Medartis Holding AG / Key word(s): Financing/Issue of Debt
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031 03-Apr-2024 / 17:43 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
12 March 2024 06:30AM
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
Medartis Holding AG / Key word(s): Annual Results
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16% 12-March-2024 / 06:30 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
15 August 2023 06:58AM
Medartis on track with 16% internal growth after 6 months
Medartis Holding AG / Key word(s): Half Year Results
Medartis on track with 16% internal growth after 6 months
15-Aug-2023 / 06:58 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
25 July 2023 09:00AM
Medartis 2023 half-year results presentation
Medartis Holding AG
/ Key word(s): Half Year Results
Medartis 2023 half-year results presentation
25.07.2023 / 09:00 CET/CEST
INVITATION │ AUDIO WEBCAST
We are pleased to invite you to our H1 2023 results presentation on 15 August 2023. The following documents will be published on our corporate website ...
Medartis Holding AG
25 July 2023 09:00AM
Medartis 2023 half-year results presentation
Medartis Holding AG
/ Key word(s): Half Year Results
Medartis 2023 half-year results presentation
25.07.2023 / 09:00 CET/CEST
INVITATION │ AUDIO WEBCAST
We are pleased to invite you to our H1 2023 results presentation on 15 August 2023. The following documents will be published on our corporate website ...
Medartis Holding AG
21 April 2023 03:08PM
Medartis shareholders approve all proposals at the AGM 2023
Medartis Holding AG
/ Key word(s): AGMEGM
Medartis shareholders approve all proposals at the AGM 2023
21.04.2023 / 15:08 CET/CEST
PRESS RELEASE82.0% of the total share capital was represented at this year's Annual General Meeting
All proposals by the Board of Directors were approved with a large majority
Adjusted Articles of ...
Medartis Holding AG
21 April 2023 03:08PM
Medartis shareholders approve all proposals at the AGM 2023
Medartis Holding AG
/ Key word(s): AGMEGM
Medartis shareholders approve all proposals at the AGM 2023
21.04.2023 / 15:08 CET/CEST
PRESS RELEASE82.0% of the total share capital was represented at this year's Annual General Meeting
All proposals by the Board of Directors were approved with a large majority
Adjusted Articles of ...
Medartis Holding AG
17 March 2023 07:00AM
Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
Medartis Holding AG / Key word(s): Capital Increase
Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
17-March-2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
17 March 2023 07:00AM
Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
Medartis Holding AG / Key word(s): Capital Increase
Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
17-March-2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
14 March 2023 06:31AM
Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth
Medartis Holding AG / Key word(s): Annual Results
Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth
14-March-2023 / 06:31 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
14 March 2023 06:31AM
Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth
Medartis Holding AG / Key word(s): Annual Results
Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth
14-March-2023 / 06:31 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
16 February 2023 08:00AM
Medartis 2022 full-year results presentation
Medartis Holding AG
/ Key word(s): Annual Results
Medartis 2022 full-year results presentation
16.02.2023 / 08:00 CET/CEST
INVITATION │ WEBCAST
We are pleased to invite you to our FY 2022 results presentation on 14 March 2023. The following documents will be published our on our corporate website and distribute to our newsle...
Medartis Holding AG
16 February 2023 08:00AM
Medartis 2022 full-year results presentation
Medartis Holding AG
/ Key word(s): Annual Results
Medartis 2022 full-year results presentation
16.02.2023 / 08:00 CET/CEST
INVITATION │ WEBCAST
We are pleased to invite you to our FY 2022 results presentation on 14 March 2023. The following documents will be published our on our corporate website and distribute to our newsle...
Medartis Holding AG
16 August 2022 06:59AM
Medartis reports 20% sales growth and makes further progress in strengthening its US organisation
Medartis Holding AG / Key word(s): Half Year Results
Medartis reports 20% sales growth and makes further progress in strengthening its US organisation
16-Aug-2022 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
16 August 2022 06:59AM
Medartis reports 20% sales growth and makes further progress in strengthening its US organisation
Medartis Holding AG / Key word(s): Half Year Results
Medartis reports 20% sales growth and makes further progress in strengthening its US organisation
16-Aug-2022 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
03 May 2022 07:00AM
Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership
Medartis Holding AG / Key word(s): Acquisition/Personnel
Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership
03-May-2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
08 April 2022 08:56AM
Medartis has decided not to pursue the convertible bond placement
Medartis Holding AG / Key word(s): Bond/Financing
Medartis has decided not to pursue the convertible bond placement
08-Apr-2022 / 08:56 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
07 April 2022 05:39PM
Medartis launches senior convertible bond offering with a target size of CHF 125-150 million
Medartis Holding AG / Key word(s): Bond/Financing
Medartis launches senior convertible bond offering with a target size of CHF 125-150 million
07-Apr-2022 / 17:39 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
Medartis Holding AG
06 April 2022 01:35PM
Medartis shareholders approve all proposals of the Board of Directors
Medartis Holding AG
/ Key word(s): AGMEGM
Medartis shareholders approve all proposals of the Board of Directors
06.04.2022 / 13:35
PRESS RELEASE84.8% of the total share capital was represented at this year's Annual General Meeting
All proposals of the Board of Directors were approved with a large majority
Ms. Nadia Tarolli S...
Medartis Holding AG
07 March 2022 06:31AM
Strong sales growth and further margin improvements - important acquisition to accelerate the US extremities business
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Total net sales increased by 24.8% year-on-year at CER[1]
All regions grew by more than 20% CER - 29% growth in the US and 22% in EMEA
Strong growth led to higher margins at all levels - EBITDA and EBIT margins improved by 2.3 and 3.8 percentage points (PP)
Net profit increased to CHF 6.9m (basic EPS 0...
Medartis Holding AG
17 August 2021 06:30AM
Medartis accelerates sales growth to 29% in H1 2021 and improves profitability
PRESS RELEASE
Medartis accelerates sales growth to 29% in H1 2021 and improves profitability
- Total net sales in the first six months rose by 29.2% at CER[1] vs. prior year (+20.6% vs. 2019)
- All regions grew by more than 20% - CER growth was strongest in the US (46.3%), followed by APAC (34.9%), LATAM (31.7%) and EMEA (22.3%)
- KeriMedical pa...
Medartis Holding AG
23 April 2021 05:45PM
Medartis Holding AG: Annual General Meeting approves all proposals of the Board of Directors and elects Marco Gadola as the new Chairman of the Board of Directors
Medartis Holding AG
Hochbergerstrasse 60E
CH-4057 Basel
PRESS RELEASE
Annual General Meeting approves all proposals of the Board of Directors and elects Marco Gadola as the new Chairman of the Board of Directors
Basel, Switzerland, 23 April 2021 - At today's Annual General Meeting of Medartis Holding AG (SIX: MED), shareholders approved all the p...
Medartis Holding AG
11 December 2020 06:59AM
Medartis appoints Dirk Kirsten as Chief Financial Officer and EMB member
Medartis Holding AG
Hochbergerstrasse 60E
CH-4057 Basel
PRESS RELEASE
Medartis appoints Dirk Kirsten as Chief Financial Officer
Basel, Switzerland, 11 December 2020 - The Board of Directors of Medartis Holding AG (SIX: MED) has appointed Dirk Kirsten as new Chief Financial Officer and Member of the Executive Management Board. He will join Medart...
Medartis Holding AG
01 December 2020 06:59AM
Medartis announces strategic partnership with KeriMedical
Medartis Holding AG
Hochbergerstrasse 60E
CH-4057 Basel
PRESS RELEASEMedartis acquires stake in KeriMedical and strengthens its extremities portfolio
Basel, Switzerland, 1 December 2020 - Medartis Holding AG (SIX: MED) has acquired a strategic minority stake in KeriMedical, a Geneva-based company specialized in implants for hand and wrist surgery....
Medartis Holding AG
18 August 2020 07:00AM
Medartis Holding AG: Press release 2020 half-year results and change in Executive Management Board
Medartis Holding AG
Hochbergerstrasse 60E
CH-4057 Basel
PRESS RELEASE
Medartis announces half-year 2020 results and a change in the Executive Management Board
Basel, Switzerland, 18 August 2020 - Medartis Holding AG (SIX: MED), a leading manufacturer and provider of medical devices for surgical fixation of bone fractures, achieved a sales result ...
Medartis Holding AG
More Medartis Holding AG related information
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 0 | - | - | DD |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.
v.07062023 EN